We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.49B
AUM Growth
-$343M
(-3.9%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-2.94%
Top 10 Holdings %
Top 10 Hldgs %
16.07%
Holding
2,271
New
51
Increased
125
Reduced
935
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.3M |
| 2 |
Baxter International
BAX
|
+$9.74M |
| 3 |
Archer Daniels Midland
ADM
|
+$6.88M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$6.54M |
| 5 |
Nektar Therapeutics
NKTR
|
+$4.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$17.1M |
| 2 |
Apple
AAPL
|
+$10.6M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$10.1M |
| 4 |
AvalonBay Communities
AVB
|
+$7.62M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$6.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.14% |
| 2 | Financials | 17.01% |
| 3 | Healthcare | 12.77% |
| 4 | Industrials | 11.29% |
| 5 | Consumer Discretionary | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ross Stores
ROST
$78.6B
| $8.97M | 0.11% |
115,002
-4,303
| -4% | -$341K |
|
|
FISV
177
Fiserv Inc
FISV
$29.5B
| $8.87M | 0.1% |
124,352
-4,608
| -4% | -$324K |
|
178
Edwards Lifesciences
EW
$53.4B
| $8.82M | 0.1% |
189,612
-6,819
| -3% | -$296K |
|
|
PXD
179
DELISTED
Pioneer Natural Resource Co.
PXD
| $8.8M | 0.1% |
51,250
-1,401
| -3% | -$247K |
|
180
McKesson
MCK
$99.9B
| $8.75M | 0.1% |
62,096
-2,408
| -4% | -$375K |
|
181
Roper Technologies
ROP
$39.3B
| $8.69M | 0.1% |
30,945
-727
| -2% | -$201K |
|
182
Sysco
SYY
$40B
| $8.66M | 0.1% |
144,500
-3,821
| -3% | -$231K |
|
183
DXC Technology
DXC
$1.79B
| $8.63M | 0.1% |
99,240
-2,793
| -3% | -$244K |
|
184
Kinder Morgan
KMI
$71.5B
| $8.6M | 0.1% |
570,947
-23,298
| -4% | -$404K |
|
185
PPG Industries
PPG
$25.5B
| $8.55M | 0.1% |
76,582
-2,155
| -3% | -$249K |
|
186
Sempra
SRE
$56.6B
| $8.55M | 0.1% |
153,674
-1,698
| -1% | -$91.6K |
|
187
Yum! Brands
YUM
$41.2B
| $8.52M | 0.1% |
100,066
-4,203
| -4% | -$345K |
|
188
MSCI
MSCI
$41.8B
| $8.39M | 0.1% |
56,130
-852
| -1% | -$122K |
|
189
M&T Bank
MTB
$36.6B
| $8.33M | 0.1% |
45,194
-1,377
| -3% | -$257K |
|
190
Autodesk
ADSK
$54.5B
| $8.32M | 0.1% |
66,287
-1,533
| -2% | -$183K |
|
191
Hewlett Packard
HPE
$79.2B
| $8.27M | 0.1% |
471,571
-21,935
| -4% | -$373K |
|
192
Western Digital
WDC
$168B
| $8.26M | 0.1% |
118,471
-2,609
| -2% | -$176K |
|
193
HCA Healthcare
HCA
$89.2B
| $8.17M | 0.1% |
84,240
-3,397
| -4% | -$330K |
|
194
Moody's
MCO
$84.6B
| $8.07M | 0.1% |
50,033
-1,408
| -3% | -$228K |
|
195
Carnival Corporation Ltd
CCL
$38.9B
| $8.01M | 0.09% |
122,172
-4,013
| -3% | -$273K |
|
196
Regeneron Pharmaceuticals
REGN
$83B
| $8M | 0.09% |
23,240
-596
| -3% | -$207K |
|
197
Broadridge
BR
$19.6B
| $7.99M | 0.09% |
72,799
-945
| -1% | -$93.8K |
|
|
RHT
198
DELISTED
Red Hat Inc
RHT
| $7.96M | 0.09% |
53,267
-1,482
| -3% | -$205K |
|
199
Weyerhaeuser
WY
$17.9B
| $7.96M | 0.09% |
227,276
-6,274
| -3% | -$221K |
|
200
T. Rowe Price
TROW
$23.7B
| $7.95M | 0.09% |
73,609
-1,364
| -2% | -$152K |
|
Similar funds
PCM
CS
HHII
EIM
P
BPA
NAM
MetLife Investment Management's Q1 2018 Portfolio in Review
As of Q1 2018, MetLife Investment Management held 2,271 positions worth $8.49B, down 3.9% from $8.84B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
MetLife Investment Management's Q1 2018 filing shows 51 new, 125 increased, 935 reduced and 90 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M. The largest sale was Bank of New York Mellon, an estimated $17.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q1 2018 buy was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $25.3M increase.
- MetLife Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $10.6M.
- MetLife Investment Management fully exited Bank of New York Mellon in Q1 2018, selling an estimated $17.1M.
- MetLife Investment Management's ten largest holdings make up 16% of its $8.49B portfolio in Q1 2018.
- MetLife Investment Management opened 51 new positions and closed 90 in Q1 2018.
- MetLife Investment Management's portfolio value fell 3.9% quarter-over-quarter to $8.49B.
Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.